HLS Therapeutics Inc. HLS.TO
Set alert
As of Nov 2, 3:59 PM ET
- YTD
- -7.26%
- 1 year
- -19.89%
- Open
- 4.49
- Prev close
- 4.51
- Mkt cap
- 138.28M
- Vol
- 10.90K
- Avg vol
- 74.02K
- EPS
- -0.37
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.41
- High
- 4.62
- Forward P/E
- -7.50
- Beta
- 1.07
- Short ratio
- 0.10
- Inst. own
- 65.14%
- Dividend
- 0.00
- Ex-div date
- Apr 26, 2023
- 50-d avg
- 3.54
- 200-d avg
- 3.70
- 1y target
- 6.09
2Y chart
Signals (80)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 27, 2026 | 6 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| RSI: Oversold | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 23, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 22, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 7, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
Newest 20 of 80.
Key statistics
- Market cap
- 119.22M
- Enterprise value
- 173.16M
- Trailing P/E
- 0.00
- Forward P/E
- -7.50
- PEG ratio
- 0.00
- Price / sales
- 2.09
- Price / book
- 1.50
- EPS (TTM)
- -0.99
- Beta
- 1.07
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -38.70%
- Revenue (TTM)
- 56.94M
- Revenue growth
- -12.20%
- Free cash flow
- 27.20M
- Total cash
- 17.54M
- Total debt
- 68.62M
- Return on equity
- -24.33%
- Shares outstanding
- 31.79M
- Short % of float
- 0.00%
- 50-day average
- 3.54
- 200-day average
- 3.70
Analyst view
Consensus: none
- Target (low)
- 3.61
- Target (mean)
- 6.09
- Target (high)
- 9.81
- Strong buy0
- Buy2
- Hold3
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.09.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 18, 2024 | Raymond James | main | Market Perform | Market Perform |
| Aug 6, 2021 | Raymond James | down | Outperform | Market Perform |
About HLS Therapeutics Inc.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- hlstherapeutics.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on HLS.TO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Canoe Financial LP | 1.54% | 499,001 | 1.87M | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| DFA Investment Dimensions-Canadian Small Company Series | 0.06% | 20,104 | 75.39K | Jul 30, 2024 |
| Highland Fds II-Highland Global Allocation Fd | 0.03% | 10,445 | 39.17K | Sep 29, 2024 |
| DFA Investment Dimensions-DFA Va International Small | 0.01% | 2,903 | 10.89K | Jul 30, 2024 |
| DFA Investment Dimensions-World Ex U.S. Core Equity Port | 0.01% | 2,000 | 7.50K | Jul 30, 2024 |
| Lincoln VIP Tr-Dimensional International Core Equity Fd | 0.01% | 2,317 | 8.69K | Sep 29, 2024 |
| John Hancock Fds II-International Small Company Fund | 0.01% | 2,600 | 9.75K | Oct 30, 2024 |